- Reaction score
- 50
The patent model for funding drug development is broken. 2009 paper by Harvard Law professor explains how thousands of viable drug candidates are quietly screened out by the pharmaceutical industry at pre-clinical stage due to insufficient patent protection.
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1127742
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1127742
